Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Molecular markers in reflux esophagitis, Barrett's esophagus and esophageal adenocarcinoma
2007-002031-92Phase 2Completed
- Sponsor
- Otto von Guericke University Magdeburg
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of esomeprazole in gastroesophageal reflux disease (GERD), Barrett's esophagus and esophageal adenocarcinoma (EAC), sponsored by Otto von Guericke University Magdeburg. Primary endpoint: Primary. Started Jul 2009; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)Barrett's esophagusesophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on 2007-002031-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002031-92.